WealthPLAN Partners’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
CCA
AWM
KF
OIA
CGA
WealthPLAN Partners's BTAL Position: Q2 2026 in Review
WealthPLAN Partners increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 77% in Q2 2026, buying an estimated $103K and bringing the position to 19,532 shares worth $218K. The position accounts for 0.04% of the portfolio, ranked #208.
WealthPLAN Partners first reported a position in BTAL in Q1 2026 and has held it in 2 quarters since. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.
- WealthPLAN Partners held 19,532 shares of AGF US Market Neutral Anti-Beta Fund worth $218K as of Q2 2026.
- WealthPLAN Partners bought 8,483 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $103K.
- AGF US Market Neutral Anti-Beta Fund made up 0.04% of WealthPLAN Partners's portfolio in Q2 2026, its #208 holding.
- WealthPLAN Partners first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2026 and has held it in 2 quarters since.
- 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.
Based on WealthPLAN Partners's 13F filing for Q2 2026, filed 28 Jul 2026.